- Wellgistics declares non-binding letter of intent with Datavault AI.
- The initiative goals at digitizing prescription from issuance to success.
- Here is why it is not as huge for WGRX inventory as market is making it to be.
Wellgistics Well being Inc (NASDAQ: WGRX) greater than tripled this morning after saying a non-binding letter of intent with Datavault AI Inc. (NASDAQ: DVLT).
The initiative dubbed “PharmacyChain” will combine blockchain-enabled sensible contracts into its prescription drug monitoring system.
Briefly, it goals at digitising the journey of a prescription from issuance to fulfilment.
Whereas the announcement sparked a frenzy of retail investor curiosity, sending WGRX refill from 40 cents to as a lot as $1.30, the worth motion seems to be operating far forward of any confirmed business traction.
Why did Wellgistics inventory soar on Friday?
On paper, the partnership faucets into two of the market’s hottest themes: blockchain and healthcare digitisation.
PharmacyChain guarantees to carry transparency and traceability to the $600 billion US prescription drug market by making certain that drugs attain the correct affected person with the correct information path.
The businesses additionally floated the thought of a revenue-sharing mannequin primarily based on pharmacy utilization charges, hinting at a possible recurring earnings stream.
For a microcap title like Wellgistics inventory, the slightest chance of a scalable tech platform can ignite speculative shopping for.
The Datavault announcement additionally aligns with WGRX’s broader push into synthetic intelligence (AI) enabled pharmacy instruments – together with its just lately launched HubRx AI platform.
Is the WGRX share value surge dependable?
Past the aforementioned flashy headline, Wellgistics’ fundamentals inform a extra sobering story.
The Tampa-headquartered agency stays a penny inventory with no historical past of sustained profitability.
Plus, the PharmacyChain deal remains to be in its exploratory part – non-binding and with out disclosed monetary phrases or deployment timelines.
That makes the over 200% improve in WGRX share value look extra like a momentum commerce than a valuation reset.
With out concrete income or adoption metrics, Wellgistics might simply retrace a lot of its latest positive factors within the coming classes.
In the meantime, the Nasdaq-listed agency lacks information on insider trades as properly – additional strengthening the bear case.
And naturally, it’s not like WGRX at the moment pays a dividend to tackle these aforementioned dangers.
Due to this fact, chasing the momentum in it after the blockchain information is far more like a chance than a sound funding.
How Wall Avenue recommends taking part in Wellgistics
Wellgistics shares will not be lined by any main Wall Avenue agency – and that lack of institutional oversight is a pink flag for risk-conscious traders.
The corporate trades on low quantity and stays in penny inventory territory, which regularly attracts speculative flows, pump-and-dump behaviour, however lacks the liquidity and transparency of extra established names.
The absence of analyst protection additionally means there’s no consensus on valuation, earnings potential, or aggressive positioning.
For now, WGRX inventory stays a high-risk, high-volatility play – higher fitted to merchants chasing headlines than long-term traders in search of sturdy development.
Till the blockchain imaginative and prescient turns into verifiable income, scepticism is warranted.
